Solaris Nutraceuticals and Southern Cross University Team Up for Pain Relief Joint Venture

VANCOUVER and SYDNEY, New South Wales, Feb. 20, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, and its strategic partner MYM Nutraceuticals (CSE: MYM) are pleased to announce a joint venture agreement between Southern Cross University and Solaris Nutraceuticals to commit to the development of hemp and medicinal cannabis products in the NSW Northern Rivers region that will enhance animal and human health. The agreement will pave the way for a flourishing industry built on the medicinal value of cannabis.


Vice-Chancellor Professor Adam Shoemaker said the agreement was a great step forward not just for the region, but also for consumers.

“Universities have a vital role to play as catalysts for diversification and development – creating new opportunities through 21st century industries,” said Professor Shoemaker. “Legalized cannabis products are already playing a critically important role in delivering medicines, and through innovation, have the potential to improve the lives of millions more through new medical applications and nutrition. This agreement is a great example of Southern Cross University’s commitment to engaging with industry and the community, so that we can create an environment for discovery and commercial development, driving changes in our back yard that can translate into benefits around the world.”

Canopy Growth obtains license for first mega-scale BC facility

Aldergrove Licence Secures Canopy with more than a Million sq. ft. of Licensed Production


ALDERGROVE, BC, Feb. 20, 2018 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) is pleased to announce that it has received a cultivation licence for the first of its two sites operating under the BC Tweed Joint Venture Inc. (“BC Tweed”) banner.



The rapid licensing of the Aldergrove site, the largest federally licensed cannabis site anywhere in the world, continues a pattern of professional execution for the Company as it prepares to meet an unprecedented increase in demand in a few short months once legal adult-use markets commence. The initial licensing covers over 400,000 sq. ft. of growing space, allowing vegetative growth so that the mature plants can be spread into the full 1.3 million sq. ft. in the coming months for flowering and ultimate harvest.

Canopy Growth successful in bid to operate private retail stores in Manitoba Français

SMITHS FALLS, ON, Feb. 16, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Company”) is pleased to announce that it has been conditionally selected by the Government of Manitoba to operate cannabis retail stores in the province after a rigorous and highly competitive RFP process. Canopy Growth, along with its partner Delta 9, is one of four successful candidates chosen to operate a number of retail locations throughout the province. Further details on locations and store quantities will follow as the RFP process is finalized.



Once official, this will mark Canopy Growth’s second provincial retail agreement after previously announcing plans to apply to operate four retail stores in the Province of Newfoundland & Labrador. To date, four provinces in Canada have put forward their retail and supply frameworks including New Brunswick, Newfoundland & Labrador, and Prince Edward Island; and all of them have chosen Canopy Growth as a trusted partner and supplier. Just this week, Canopy Growth also entered into a Letter of Intent (LOI) with the province of Quebec to supply up to 12,000 kg of cannabis in that province annually.

Hiku Brands awarded prized retail cannabis license in Manitoba

TORONTO, Feb. 16, 2018 /CNW/ – Hiku Brands Company Ltd. (“Hiku” or the “Company”) (CSE: HIKU), is pleased to announce that its wholly-owned subsidiary, Tokyo Smoke, with participation by BOBHQ, has been conditionally awarded one of four master retail licenses (the “License”) in Manitoba’s highly competitive Request for Proposal (“RFP”) process for the right to operate retail cannabis stores. The License gives Tokyo Smoke the ability to operate legal retail cannabis stores and an online cannabis sales platform in Manitoba. This represents a significant milestone for Hiku and BOBHQ as one of only four successful entities selected in a highly competitive process.

Hiku is excited to bring its award winning retail experience to Manitoba and Manitoba cannabis consumers. The Company commends the leadership shown by the Province of Manitoba in setting up a competitive, privatized cannabis retail system to ensure the responsible management of cannabis distribution and sales within the province ahead of the anticipated adult-use legalization date of Summer 2018.

Sunniva Inc. to Commence Trading on the OTCQX Market

VANCOUVER, Feb. 14, 2018 /CNW/ – Sunniva Inc. (“Sunniva” or “the Company”) (CSE:SNN) (OTCQX:SNNVF), a North American provider of medical cannabis products and services, is pleased to announce that effective February 15, 2018, common shares of the Company (“Shares”) have been approved for and will commence trading on the OTCQX Market, operated by OTC Markets Group.  The Shares will trade under the ticker symbol “SNNVF”.

The OTCQX Market provides investors who cannot access trading on the Canadian Securities Exchange with an alternative access to Sunniva’s Shares though regulated US broker-dealers.

“Sunniva’s expansion into the US securities markets is a milestone that brings the Company substantially added access to investors.  We are confident that trading on OTCQX can enhance liquidity for our shareholders and extend investor awareness of the Company throughout the US and beyond,” said Dr. Anthony Holler, CEO, Sunniva.

MedReleaf signs LOI to supply the Province of Quebec with 8 tons of cannabis for the adult use market

Deal marks first recreational contract for the Company

MARKHAM, ON, Feb. 14, 2018 /CNW/ – MedReleaf Corp. (TSX:LEAF) (“MedReleaf” or the “Company”), Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced that it has signed a Letter of Intent (“LOI”) with Société des alcools du Québec (“SAQ”) to supply the Province of Quebec with a guaranteed volume of high quality adult recreational-use cannabis.

Under the terms of the LOI, MedReleaf will supply the Quebec market with a minimum of 8,000 kilograms of cannabis products per year.

“We are proud to be working with SAQ, one of the largest purchasers of alcohol in the world, to ensure the safe, reliable, and responsible distribution of adult-used cannabis,” said Neil Closner, CEO of MedReleaf. “Our capacity expansion in Bradford is on track, and we look forward to delivering an assortment of our award-winning cannabis products and brands to the Province of Quebec in the first year of this agreement.”

Aphria signs letter of intent with SAQ to supply up to 12,000 kg of cannabis annually to Quebec market Français

Aphria becomes one of the first suppliers of adult-use cannabis to La Belle Province

LEAMINGTON, ON, Feb. 14, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has signed a Letter of Intent with the Société des alcools du Québec (“SAQ”) to guarantee a supply of high-quality, safe and clean cannabis products for sale in the Quebec adult-use market through their retail outlets and e-commerce platform.

“We’re thrilled to partner with the SAQ to supply the Quebec adult-use market with a variety of high-quality, safe and pure cannabis products,” said Vic Neufeld, Chief Executive Officer of Aphria. Aphria is uniquely positioned to meet the anticipated demand in Canada’s second-largest market and we are pleased to be working closely with the SAQ and its management team as one of the first suppliers to the province.”

SMITHS FALLS, ON, Feb. 14, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Company”) today announced that it has signed a letter of intent with the Société des alcools du Québec (“SAQ”) to provide the Quebec market with 12,000 kilos of high-quality cannabis annually.

This announcement marks Canopy Growth’s fourth and largest supply agreement to-date, following previous agreements with the Provinces of New Brunswick, Newfoundland and Labrador, and Prince Edward Island. Three provinces have now announced supply arrangements with Licensed Producers, all of which include Canopy Growth. The Company now has more supply commitments than any other Licensed Producer in the country.

Valens GroWorks closes final tranche of $12.38 million financing

VANCOUVER, Feb. 13, 2018 /CNW/ – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licenced, vertically integrated provider of cannabis products, is pleased to announce the closing of the second and final tranche (the “Final Tranche”) of its previously announced non-brokered private placement of common shares in the capital of the Company at a price of $1.40 per share (the “Offering”).

Pursuant to the over-subscribed Final Tranche, the Company issued 6,848,817 common shares for gross proceeds of $9,588,344. Certain eligible persons (“Finders”) were paid a cash fee equal to 8% of the proceeds raised from subscribers introduced by such Finders, a portion of such fees which were settled by the issuance of an aggregate of 70,565 common shares to such Finders.

MedReleaf introduces first adult-use recreational cannabis brand: San Rafael '71 launches with cannabis-inspired beer

MARKHAM, ON, Feb. 9, 2018 /CNW/ – MedReleaf Corp. (TSX:LEAF) Canada’s first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced the introduction of its first adult-use recreational brand: San Rafael ’71, inspired by and designed to celebrate the spirit of classic cannabis culture.

San Rafael ’71 has been designed with the classic consumer in mind, one of the largest segments of the Canadian cannabis market. San Rafael ’71 is for adults who are discerning and knowledgeable about cannabis products and those who value quality and an authentic experience.

Island Garden signs Craft Grow agreement with Canopy

SMITHS FALLS, ONApril 19, 2017 /CNW/ – Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or “the Company”), is pleased to announce the launch of Tweed’s curated CraftGrow line, which brings high quality cannabis grown by a diverse set of producers to Tweed Main Street’s customers. In line with the level of variety customers have come to expect, Tweed will proudly showcase the history and unique growing methods of each CraftGrow producer.

“Our company recognizes the diverse needs of patients and is proud to bring them the highest quality products that we grow in our own facilities, while introducing them to producers that each bring a unique offering forward,” said Bruce Linton, Chairman & CEO, Canopy Growth. “Telling the story of cannabis cultivators, big and small, is essential to a successful market for medical cannabis. Having put together the infrastructure of over 100 customer care staff, as well as packing and fulfilment staff capable of shipping thousands of orders a day, we are in a unique position to support smaller producers getting to market, and to help patients find the products they need from an ever wider selection.”

DOJA Cannabis Raises $12.5 Million in Advance of Tokyo Smoke Merger

KELOWNA, BC, Jan. 9, 2018 /CNW/ – DOJA Cannabis Company Limited (“DOJA” or the “Company”) (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts (the “Subscription Receipts”) whereby Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39 for gross proceeds of $12,500,001.73 (the “Offering”).


“We’re thrilled to have strategic partners in Aphria and Koicha Partners. Once the merger with Tokyo Smoke goes through, this strategic investment will strengthen Hiku, financially as well as through its brand recognition and product and market reach. Expanding Hiku’s retail footprint, targeting provinces allowing private cannabis retail, and building a portfolio of recognizable consumer brands and products will be key differentiators for Hiku.”

Harvest One to Raise $25 Million Selling Units at $1.82

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jan. 9, 2018) – Harvest One Cannabis Inc. (TSX VENTURE: HVST) (“Harvest One” or the “Company”) is pleased to announce that is has entered into an agreement with Mackie Research Capital Corporation (as the lead underwriter and sole bookrunner, “Mackie Research”), on its own behalf and behalf of a syndicate of Underwriters (collectively, the “Underwriters”), to complete a $25,000,000 short form prospectus offering (the “Offering”) of units (“Units”) of the Company on a bought deal basis, at a price of $1.82 per Unit (the “Offering Price”).


Under the Offering, each Unit will consist of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”). Each Warrant shall entitle the holder thereof to purchase one Common Share (a “Warrant Share”) at an exercise price of $2.30 per Warrant Share at any time up to 24 months following the closing of the Offering.

Organigram to Raise $100 Million in Convertible Note Deal

Organigram Announces $100 Million Bought Deal Financing

MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 10, 2018) – Organigram Holdings Inc.(TSX VENTURE:OGI)(OTCQB:OGRMF) (“Organigram” or the “Company”) is pleased to announce that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase,


together with a syndicate of Underwriters (the “Underwriters”) 100,000 convertible debentures (the “Convertible Debentures”) of the Company on a “bought deal” basis pursuant to the filing of a short form prospectus, subject to all required regulatory approvals, at a price of $1,000 per Convertible Debenture (the “Issue Price”) for gross proceeds of $100,000,000 (the “Offering”).

Maricann Expects to Begin Shipping CBD to Germany in February

Maricann Announces Operational Update

BURLINGTON, ONTARIO–(Marketwired – Jan. 11, 2018) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) (“Maricann” or “The Company”), is pleased to provide investors with the following Operational Update post the closing of our recent $40MM financing.


Phase One construction of our state-of-the-art Langton, ON facility is currently on time and within 2% of budget. We anticipate planting to begin in Q2 of 2018 following a Health Canada Inspection. Initial production capacity is expected to be 22,500 kg per year.

PUF Ventures Inc. - Australia to Allow Exportation of Cannabis Products

VANCOUVERJan. 5, 2018 /CNW/ – PUF Ventures Inc. (“PUF” or the “Company“) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce the Australian government intends to expunge the export ban on cannabis products in February 2018 and allow the export of cannabis products worldwide.


“We expect significant value to be generated from our partnership in Solaris’ proposed 1.2 million square-foot green house facility in northern New South Wales, which when complete will be the largest production facility in AustraliaAustralia has a small population and we expect the export of cannabis products to grow beyond current domestic sales of medicinal cannabis.”

Hydropothecary Announces $100 Million Public Offering

TORONTOJan. 8, 2018 /CNW/ – The Hydropothecary Corporation (“THCX” or the “Company”) (TSX VENTURE:THCX) announced today that it has entered into an agreement with Canaccord Genuity Corp., Eight Capital, and a syndicate of underwriters (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 25,000,000 units of the Company (the “Units”) at a price of $4.00 per Unit for aggregate gross proceeds of $100,000,000.

Each Unit will consist of one common share (a “Common Share”) and one half of one common share purchase warrant (each full warrant, a “Warrant”) of the Company (the “Offering”).

Each Warrant will be exercisable to acquire one common share of the Company for a period of two years following the closing date of the Offering at an exercise price of $5.60 per common share, subject to adjustment in certain events.

The Company has also granted the Underwriters an option to purchase up to an additional 3,750,000 Units under the Offering at a price of $4.00 per Unit (the “Over-Allotment Option”). If the Over-Allotment Option is exercised in full, the aggregate gross proceeds of the Offering will be $115,000,000. The Over-Allotment Option is exercisable, in whole or in part, at any time up to 30 days following the date of the closing of the Offering.

CSE Launches New Index

The Canadian Securities Exchange launched a new index meant to account for the largest companies on the exchange, some of the top weighing companies in the index operate in the cannabis business.

The Canadian Securities Exchange launched a new index meant to account for the largest companies on the exchange, some of the top weighing companies in the index operate in the cannabis business.

Released earlier this week (September 18), the exchange indicated the companies on thr index, called CSE25, represent over 50 percent of the “weighting in the larger index.”

“[I]t is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues,” Richard Carleton, CEO of the CSE said in the release.

Here the Investing News Network takes a look at the top cannabis companies included in the index and their current weight as indicated by the CSE.